MedTrace Logo

Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders

NCT05120232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2025-02-07

No results posted yet for this study

Summary

This two phase study is testing an online version of a transdiagnostic, cognitive behavioral therapy, against a modified version of that therapy emphasizing positive affect. The first phase of the trial will focus on content development for the modified therapy and the second phase will be a randomized control trial comparing the two.

Conditions

  • Anxiety Disorders
  • Depressive Disorder

Interventions

BEHAVIORAL

Unified Protocol

A transdiagnostic, cognitive behavioral therapy.

BEHAVIORAL

Modified Unified Protocol (UP+)

A transdiagnostic, cognitive behavioral therapy.

Sponsors & Collaborators

  • University of Kentucky

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • Boston University Charles River Campus

    lead OTHER

Principal Investigators

  • Todd Farchione, Ph.D. · Center for Anxiety Related Disorders at Boston University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2023-07-01
Completion
2024-01-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120232 on ClinicalTrials.gov